Hepatitis C virus resistance to new specifically-targeted antiviral therapy: A public health perspective

doi:10.5501/wjv.v2.i1.6

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3978)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

377

HTML

3098

Figures (1-1)

248

Tables (1-1)

255

Sum=3978

Feb 12, 2013 (publication date) through Dec 1, 2024

Times Cited of This Article

Times Cited (18)

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireview

World J Virol. Feb 12, 2013; 2(1): 6-15
Published online Feb 12, 2013. doi: 10.5501/wjv.v2.i1.6

Open in New Tab Full Size Figure Download Figure

Figure 1 Diagram of the hepatitis C virus genes and the viral polyprotein, with two non-coding regions in the 5’ and 3’ ends of the viral genome, structural (with) and non-structural (grey) proteins. The targets for the most-developed Specifically-Targeted Antiviral-Treatment for hepatitis C compounds are indicated, together with drugs in advanced development.

Citation: Salvatierra K, Fareleski S, Forcada A, López-Labrador FX. Hepatitis C virus resistance to new specifically-targeted antiviral therapy: A public health perspective. World J Virol 2013; 2(1): 6-15
URL: https://www.wjgnet.com/2220-3249/full/v2/i1/6.htm
DOI: https://dx.doi.org/10.5501/wjv.v2.i1.6